Crizotinib for ROS1‐rearranged lung cancer and pulmonary tumor thrombotic microangiopathy under venoarterial extracorporeal membrane oxygenation-Reference-Cited by-同舟云学术

Crizotinib for ROS1‐rearranged lung cancer and pulmonary tumor thrombotic microangiopathy under venoarterial extracorporeal membrane oxygenation

Published:2022-01 Issue:1 Volume:12 Page:
ISSN:2045-8940
Container-title:Pulmonary Circulation
language:en
Short-container-title:Pulm. circ.

Author:

Aoyama Daisetsu¹²^ORCID,Fukui Shigefumi¹³,Hirata Haruhiko⁴,Ohta‐Ogo Keiko⁵,Matama Hideo¹,Tateishi Emi⁶,Nishii Tatsuya⁶,Asaumi Yasuhide¹,Toyofuku Mamoru⁷,Ikeue Tatsuyoshi⁸,Ogo Takeshi¹,Ishibashi‐Ueda Hatsue⁵⁹,Yasuda Satoshi¹¹⁰

Affiliation:

1. Department of Cardiovascular Medicine National Cerebral and Cardiovascular Center Suita Japan

2. Department of Cardiovascular Medicine University of Fukui Fukui Japan

3. Department of Cardiovascular Medicine Tohoku Medical and Pharmaceutical University Hospital Sendai Japan

4. Department of Respiratory Medicine and Clinical Immunology Osaka University Graduate School of Medicine Suita Japan

5. Department of Pathology National Cerebral and Cardiovascular Center Suita Japan

6. Department of Radiology National Cerebral and Cardiovascular Center Suita Japan

7. Department of Cardiology Japanese Red Cross Wakayama Medical Center Wakayama Japan

8. Department of Respiratory Medicine Japanese Red Cross Wakayama Medical Center Wakayama Japan

9. Department of Diagnostic Pathology Hokusetsu General Hospital Takatsuki Japan

10. Department of Cardiovascular Medicine Tohoku University Graduate School of Medicine Sendai Japan

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pul2.12047

Reference10 articles.

1. Pulmonary tumor thrombotic microangiopathy: a systematic review

2. Pulmonary Tumor Thrombotic Microangiopathy with Circulatory Failure Treated with Imatinib

3. Possibility of venoarterial extracorporeal membranous oxygenator being a bridging therapy for hemodynamic deterioration of pulmonary tumor thrombotic microangiopathy prior to initiating chemotherapy

4. Crizotinib Therapy for Advanced Lung Adenocarcinoma and a ROS1 Rearrangement: Results From the EUROS1 Cohort

5. Platelet-derived growth factor-A and vascular endothelial growth factor-C contribute to the development of pulmonary tumor thrombotic microangiopathy in gastric cancer

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pulmonary tumor thrombotic microangiopathy: Two case reports and literature review;Medicine;2024-06-28

2. Outcomes of Patients With Cancer With Myocardial Infarction-Associated Cardiogenic Shock Managed With Mechanical Circulatory Support;Journal of the Society for Cardiovascular Angiography & Interventions;2023-11